DEF6 deficiency, a mendelian susceptibility to EBV infection, lymphoma, and autoimmunity - 04/02/21
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
This study was funded by the Ligue Contre le Cancer-Equipe Labellisée (France) (to S.L.), INSERM (France), Rare Diseases Foundation (to S.L.) (France), ANR-14-CE14-0028-01 (to S.L.), ANR 18-CE15-0025-01 (to S.L.), “Investissements d'avenir” program ANR-10-IAHU-01 (Imagine Institute), the Société Française Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent, AREMIG (France), Fédération Enfants et Santé (to S.L.) (France). B.F. is the recipient of a Fondation pour la Recherche Médicale fellowship (FDM20170638301) (France). D.J.C. was supported by the Imagine Institute PhD program funded by the Fondation Bettencourt Schueller. S.L. is a senior scientist at the Centre National de la Recherche Scientifique-CNRS (France). |
|
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 147 - N° 2
P. 740 - Febbraio 2021 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?